From Hype to Reality: Applications of Generative AI in HEOR and Market Access

Speaker(s)

Moderator: Jag Chhatwal, PhD, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Wilmington, MA, USA
Panelists: Turgay Ayer, PhD, Georgia Institute of Technology , ValueGen.AI/Value Analytics Labs, Atlanta, GA, USA; Sanatan Shreay, PhD, MS, Health Economics and Outcomes Research, Cytokinetics, South San Francisco, CA, USA; Rachael Fleurence, PhD, National Institutes of Health, Bethesda, MD, USA; Francesco De Solda, PharmD, MBA, Janssen Global Services LLC, Raritan, NJ, USA; Ipek Ozer Stillman, MS, MBA, Takeda Pharmaceuticals, Boston, MA, USA

The rapid evolution of generative artificial intelligence (AI) from a burgeoning concept to a transformative technology heralds a new era for Health Economics and Outcomes Research (HEOR) and Market Access. This educational symposium aims to demystify the applications and real-world use cases of generative AI, bridging the gap between theoretical potential and practical utility. Join us as leading experts offer insights into how generative AI can transform the landscape of HEOR and Market Access.

Dr. Chhatwal will moderate the session, setting the stage with an insightful introduction into the current landscape and potential of generative AI in healthcare, aiming to provide a foundational understanding for all attendees. The symposium will delve deeper into the intricacies of generative AI with Dr. Ayer exploring the current state of technology and addressing the challenges posed by the limitations of commonly available large language models (LLMs). Dr. Ayer will also highlight the critical need for developing niche-LLMs tailored for the unique demands of HEOR and market access. Next, Dr. Ozer-Stillman will share examples where LLMs are transforming HEOR practice. Dr. Shreay will showcase practical examples where generative AI could be a boon for Market Access, illustrating the technology’s capacity to enhance research outcomes and decision-making processes. Dr. Fleurence will discuss the integration of Real-World Evidence (RWE) and Real-World Data (RWD) with generative AI, offering insights into how these collaborations can yield novel insights and drive HEOR field forward. Lastly, Dr. De Solda will highlight how generative AI complements traditional AI in HEOR and market access, thereby offering strategic advantages.

Through these expert-led sessions, the symposium aims to equip attendees with a comprehensive understanding of generative AI’s role in HEOR and market access, fostering a future where healthcare and technology synergize to improve outcomes and accessibility.

Code

235

Topic

Health Technology Assessment